Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glory Health IndustryFRA:84R -9.09%35 Debt-to-EBITDA is -22.48 as of Dec. 2025. GuruFocus rates FRA:84R with a GF Score™ of 35/100. The stock has 5 warning signs investors should review. Among 1,271 Real Estate companies, Glory Health Industry ranks worse than 78678.13% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Glory Health Industry's Debt-to-EBITDA or its related term are showing as below:
FRA:84R'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -189.53 Med: 6.9 Max: 21.54
Current: -29.08
During the past 13 years, the highest Debt-to-EBITDA Ratio of Glory Health Industry was 21.54. The lowest was -189.53. And the median was 6.90.
FRA:84R's Debt-to-EBITDA is ranked worse than 100% of 1271
companies
in the Real Estate industry
Industry Median: 5.5
vs FRA:84R: -29.08
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Glory Health Industry Debt-to-EBITDA Related Terms
Glory Health Industry Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Glory Health Industry's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glory Health Industry Debt-to-EBITDA Competitor Comparison
For the Real Estate - Development subindustry, Glory Health Industry's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glory Health Industry Debt-to-EBITDA vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Glory Health Industry's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Glory Health Industry's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Glory Health Industry (FRA:84R) has a Debt-to-EBITDA of -22.48 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Glory Health Industry. According to the industry distribution chart, Glory Health Industry ranks #999999 out of 1271 companies in the Real Estate industry.
Is Glory Health Industry's Debt-to-EBITDA too high?
Glory Health Industry's current Debt-to-EBITDA is -22.48. Based on the distribution chart, Glory Health Industry ranks #999999 out of 1271 companies in the Real Estate industry, which is in the bottom quartile relative to peers. Overall, Glory Health Industry has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Glory Health Industry's Debt-to-EBITDA compare to competitors?
According to the Real Estate industry distribution chart, Glory Health Industry ranks #999999 out of 1271 companies for Debt-to-EBITDA. This places Glory Health Industry in the lower half of its industry. The industry median Debt-to-EBITDA is 5.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Real Estate company?
The median Debt-to-EBITDA among Real Estate companies is 5.50, based on 1,271 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Glory Health Industry. For the Real Estate industry, the median Debt-to-EBITDA is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glory Health Industry's current Debt-to-EBITDA is -22.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glory Health Industry stock overvalued right now?
Glory Health Industry (FRA:84R) has a current Debt-to-EBITDA of -22.48. The current Debt-to-EBITDA is -22.48. Glory Health Industry's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Glory Health Industry (FRA:84R), the current Debt-to-EBITDA is -22.48 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glory Health Industry Ltd is an investment holding company. The company's operating segments are Property development that develops and sells commercial and residential properties; primary land construction and development services that derive revenue from primary land development, including services for resettlement, construction of land infrastructure, and ancillary public facilities on land owned by the local governments; Property investment that derives rental income from investment properties developed by the group; and Property management that derive income from property management and related services. The majority of the revenue is derived from the Property development segment. All the company's revenue is derived from the PRC.
35GF Score
Get the complete analysis for FRA:84R
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:84R has been successfully added to your 
